Korro Bio, Inc. (KRRO)

Korro Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0	0	0	14.07	36.98	28.95
Revenue Growth (YoY)	-	-	-	-61.96%	27.76%	-
Gross Profit	0	0	0	14.07	36.98	28.95
Selling, General & Admin	26.01	27.28	16.8	37.18	27.12	14.84
Research & Development	59.47	57.25	42.2	60.92	37.42	18.78
Other Operating Expenses	0	0	0	0	0	16
Operating Expenses	85.48	84.53	59	98.1	64.53	49.62
Operating Income	-85.48	-84.53	-59	-84.03	-27.55	-20.68
Interest Expense / Income	0.24	0	0	0.37	-0.99	-1.78
Other Expense / Income	-4.55	-3.39	-0.98	0.27	-0.08	-0.15
Pretax Income	-81.17	-81.15	-58.02	-84.67	-26.48	-18.75
Income Tax	0.02	0.03	0.01	0.02	0.04	0
Net Income	-81.19	-81.17	-58.03	-84.69	-26.51	-18.75
Preferred Dividends	0	0	0	0	0	1.05
Net Income Common	-81.19	-81.17	-58.03	-84.69	-26.51	-19.8
Shares Outstanding (Basic)	8	2	0	1	1	0
Shares Outstanding (Diluted)	8	2	0	1	1	0
Shares Change	2853.58%	499.32%	-62.86%	6.50%	272.90%	465.24%
EPS (Basic)	-27.99	-53.08	-227.42	-123.50	-41.00	-114.50
EPS (Diluted)	-27.99	-53.08	-227.42	-123.50	-41.00	-114.50
Free Cash Flow	-88.4	-75.12	-58.86	-78.97	-51.86	33.15
Free Cash Flow Per Share	-11.02	-49.12	-230.65	-114.95	-80.39	191.65
Gross Margin	-	-	-	100.00%	100.00%	100.00%
Operating Margin	-	-	-	-597.32%	-74.49%	-71.42%
Profit Margin	-	-	-	-601.98%	-71.68%	-68.40%
Free Cash Flow Margin	-	-	-	-561.37%	-140.22%	114.53%
EBITDA	-73.39	-73.91	-54.12	-80.46	-25.89	-19.72
EBITDA Margin	-	-	-	-571.96%	-70.00%	-68.11%
Depreciation & Amortization	7.54	7.24	3.91	3.84	1.58	0.81
EBIT	-80.93	-81.15	-58.02	-84.3	-27.47	-20.53
EBIT Margin	-	-	-	-599.26%	-74.28%	-70.92%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).